About Ganilk Private Limited
Data last updated:
Ganilk Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24293TN2018PTC125979. Its GSTIN is 33AAHCG5666N1Z3 (Tamil Nadu).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors including Devendra Kumar Kejriwal and Shiv Kumar Kanodia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 150 Anna Salai, Chennai, Tamil Nadu, India – 600002.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.47 Lakh, a decline of 99% compared to the previous year. For the same year it recorded a net loss of ₹19.59 Lakh and EBITDA of -₹19.59 Lakh.
For more details, the company can be reached via its website medopharm.com.
Company details
Contact details
Ganilk Private Limited's registered office is in Chennai, Tamil Nadu. Its website is medopharm.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address150 Anna Salai, Chennai, Tamil Nadu, India – 600002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ganilk Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ganilk is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ganilk Private Limited, buy the company report.
Financials of Ganilk Private Limited
FY 2025 filings availableGanilk Private Limited reported revenue of ₹2.47 Lakh (down 99% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 99% in the latest year. EBITDA fell 265% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹19.59 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹19.59 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ganilk Private Limited, buy the company report.
Board of directors of Ganilk Private Limited
Ganilk has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devendra Kumar Kejriwal Also directs: Deeya Lifescience Private Limited | Director | 19 Feb 2019 | 7 Years 8 Months | Current |
| Shiv Kumar Kanodia | Director | 27 Nov 2018 | 7 Years 11 Months | Current |
| Manish Kumar Jajodia Also directs: Anzen Exports Private Limited, Fastwell Retail Private Limited, Smick Laboratories Private Limited and 1 more | Director | 27 Nov 2018 | 7 Years 11 Months | Current |
| Udhan Kumar Chordia Also directs: Altiouss Developers LLP, Achord Aggro Private Limited, Medopharm Private Limited and 2 more | Director | 04 Dec 2018 | 7 Years 10 Months | Current |
Auditor
Ganilk Private Limited is audited by ANKUR AGARWAL for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANKUR AGARWAL | FY 2023 | 140702 |
Shareholding
The shareholding of Ganilk Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ganilk Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ganilk Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ganilk Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ganilk has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAHCG5666N1Z3 | Tamil Nadu | Active | 05 Jun 2021 |
To see the full GST registrations and return filing status of Ganilk Private Limited, buy the company report.
Recent activity
Ganilk Private Limited has 4 board changes on record since 2018: 4 appointments. The latest: Devendra Kumar Kejriwal was appointed as Director on 19 Feb 2019.
Frequently asked questions
Ganilk is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 November 2018 (8+ years old) and is registered under CIN U24293TN2018PTC125979.
Ganilk has 4 current directors:
- Devendra Kumar Kejriwal - Director
- Shiv Kumar Kanodia - Director
- Manish Kumar Jajodia - Director
- Udhan Kumar Chordia - Director
The latest financial statements of Ganilk on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Ganilk is 33AAHCG5666N1Z3, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Ganilk is U24293TN2018PTC125979. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ganilk was incorporated on 27 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.
Devendra Kumar Kejriwal was appointed as Director on 19 Feb 2019. Udhan Kumar Chordia was appointed as Director on 04 Dec 2018. Manish Kumar Jajodia was appointed as Director on 27 Nov 2018. Ganilk has 4 board changes on record in total.
Ganilk can be reached through the website medopharm.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Ganilk is at 150 Anna Salai, Chennai, Tamil Nadu, India – 600002.
Ganilk operates in the pharma industry, in the pharmaceutical retailers and distributors segment.